Multibagg AI (US) @MultibaggAIUS

JPMORGAN CHASE EARNINGS REPORT COMING SOON JPMORGAN CHASE TO RELEASE NEXT QUARTERLY EARNINGS REPORT ON 26 SEP 2025, EXPECTED TO INFLUENCE MARKET PERCEPTIONS AND INVESTMENT STRATEGIES FOR THE FINANCIAL SECTOR.

ACCENTURE'S DISAPPOINTING RESULTS IMPACT IT SECTOR ACCENTURE'S RESULTS TRIGGER A 7.4% SLUMP IN NIFTY IT INDEX OVER SIX DAYS, H-1B VISA FEE INCREASE RAISES CONCERNS ON LABOR COSTS AND HIRING PRACTICES, IMPACTING TCS, INFOSYS, AND WIPRO.

ACCENTURE GAINS MARKET SHARE IN IT SECTOR CLSA SAYS ACCENTURE IS GAINING MARKET SHARE, THREAT TO INDIAN IT FIRMS || RECOMMENDS INFOSYS, TECH MAHINDRA, PERSISTENT SYSTEMS, WIPRO || STRONG GROWTH PROSPECTS IN FINANCIAL SERVICES COULD INFLUENCE INVESTOR SENTIMENT.

ACCENTURE Q4 RESULTS HURT INDIAN IT STOCKS ACCENTURE'S Q4 PERFORMANCE DRAGS INDIAN IT STOCKS DOWN 2%, REVENUE AT $17.6B, ANNOUNCED $865M RESTRUCTURING, SIGNALS POTENTIAL HEADWINDS FOR SECTOR, DEMAND WEAKENS AMID GENERATIVE AI ADVANCES.

AAPL BOOSTS IPHONE 17 PRODUCTION AMID DEMAND APPLE INC. (NASDAQ:AAPL) SEES STRONG DEMAND FOR AFFORDABLE IPHONE 17, REQUESTS SUPPLIERS TO INCREASE PRODUCTION. THIS SHOWS ROBUST MARKET INTEREST AND COULD POSITIVELY AFFECT STOCK PERFORMANCE, ALIGNING WITH CONSUMER PREFERENCES.

MATCH GROUP FACES BIPARTISAN SCRUTINY MATCH GROUP, PARENT OF TINDER, FACING U.S. SENATORS' SCRUTINY ON USER PROTECTION, RISING ROMANCE SCAMS LEAD TO FINANCIAL LOSSES, SENATORS REQUEST DETAILED FRAUD PREVENTION RECORDS, SHARES DECLINE AMIDST SCRUTINY, POTENTIAL IMPACT ON…

TRUMP ANNOUNCES 100% TARIFF ON IMPORTED DRUGS PRESIDENT TRUMP TO IMPLEMENT A 100% TARIFF ON IMPORTED BRANDED DRUGS BEGINNING 01 OCT 2025, IMPACTING GLOBAL PHARMACEUTICALS, ESPECIALLY EXPORTERS LIKE INDIA AND CHINA || EXPECTED TO INCREASE DRUG PRICES AND AFFECT HEALTHCARE COSTS.

ACCENTURE Q4 REVENUE SOARS 7% TO $17.6B ACCENTURE CLOCKS Q4 REVENUE AT $17.6B, UP 7%, BEATING ESTIMATES, GUIDES CAUTIOUSLY FOR FY26, GROWTH CONCERNS IN INDIAN IT SECTOR RAISED, GENERATIVE AI PROJECTS ON THE RISE, BUT IT SERVICES BUDGETS REMAIN TIGHT, LOW GROWTH EXPECTED,…

ACCENTURE Q4 REVENUE GROWS 7% YOY ACCENTURE REPORTS Q4 REVENUE OF $17.6B, UP 7% YOY, FULL-YEAR REVENUE AT $69.7B || IT STOCKS IMPACTED AS INFOSYS, WIPRO ADRS FALL BY UP TO 3% || RESULTS MAY AFFECT INVESTOR SENTIMENT IN IT SECTOR

U.S. ANNOUNCES TARIF ON PHARMA IMPORTS U.S. PRESIDENT ANNOUNCES 100% TARIFF ON BRANDED, PATENTED PHARMACEUTICAL IMPORTS FROM INDIA, EFFECTIVE 1 OCT 2025 || IMPACT ON INDIAN PHARMA FIRMS LIKE DR REDDY'S, AUROBINDO, SUN PHARMA EXPECTED, AS U.S. IS A CRUCIAL MARKET FOR THEIR…

W. R. BERKLEY ANNOUNCES DIVIDEND PAYMENT W. R. BERKLEY CORPORATION DECLARES A 9 CENTS PER SHARE QUARTERLY CASH DIVIDEND, PAYABLE ON 30 SEP 2025, TO STOCKHOLDERS ON RECORD AS OF 22 SEP 2025 || SIGNIFYING COMMITMENT TO SHAREHOLDER VALUE IN THE U.S. INSURANCE MARKET.

DALLAS FED PRESIDENT PROPOSES RATE CHANGE DALLAS FED PRESIDENT LORIE LOGAN SUGGESTS REPLACING FEDERAL FUNDS RATE WITH TRI-PARTY GENERAL COLLATERAL RATE (TGCR) | AIMS TO ENHANCE MONETARY POLICY EFFECTIVENESS | EMPHASIZES TIMING CHANGE TO STABLE MARKETS TO AVOID CRISIS DECISIONS.

AI BOOM FACES SKEPTICISM AMID VALUATION CONCERNS GLOBAL FUND MANAGERS RAISE EYEBROWS ON THE AI BOOST, QUESTIONING NVIDA'S RECENT OPENAI DEAL, WARINESS GROWS OVER POTENTIAL MARKET BUBBLES AND IRRATIONAL EXUBERANCE IN TECH STOCK VALUATIONS, INCLUDING NVIDA, SIGNALING SHIFT IN…

INTEL CHASES PARTNERSHIPS TO BOOST BUSINESS INTEL SEEKS PARTNERSHIPS, WITH TSMC AS A MAIN PROSPECT, AIMING TO REVIVE ITS PERFORMANCE AMID STIFF AI CHIP COMPETITION, FOLLOWING INVESTMENTS FROM NVIDIA AND SOFTBANK. DISCUSSIONS COULD LEAD TO A JOINT VENTURE TO ENHANCE MANUFACTURING…

JPMORGAN LAUNCHES ETF FOCUSED ON US TECH JPMORGAN DEBUTS A NEW TAIWAN-LISTED ETF TARGETING US TECH, ADDING TO 19 US TECH ETFS LAUNCHED IN ASIA THIS YEAR, SIGNIFYING RISING INTEREST FROM ASIAN INVESTORS IN US TECHNOLOGY MARKETS.

TRUMP ANNOUNCES 100% TARIFF ON INDIAN DRUGS U.S. PRESIDENT DONALD TRUMP TO IMPOSE A 100% TARIFF ON BRANDED AND PATENTED DRUGS FROM INDIA, EFFECTIVE 1 OCTOBER, IMPACTING INDIAN PHARMA STOCKS LIKE SUN PHARMA AND AUROBINDO PHARMA; CONCERNS RISE OVER SECTOR-WIDE IMPACT WITHOUT U.S.…

CCEP SEES MIXED QUARTERLY RESULTS COCA-COLA EUROPACIFIC PARTNERS (CCEP) REPORTS $10.61B IN QUARTERLY REVENUE, GROWTH YOY, NET PROFIT DECLINES || DEUTSCHE BANK REAFFIRMS BUY WITH $8,130 TARGET, BARCLAYS MAINTAINS BUY AT $103, OVERALL ANALYST CONSENSUS SAYS MODERATE BUY.

U.S. ESCALATES TARIFFS ON BRANDED DRUGS U.S. ANNOUNCES 100% TARIFF ON BRANDED DRUGS, INTENSIFYING TRADE TENSIONS WITH INDIA FACING 50% TARIFF, SIGNIFICANT IMPACT ON INDIA'S PHARMACEUTICAL SECTOR EXPECTED, POTENTIAL PRICE RISE FOR CONSUMERS, ONGOING U.S.-INDIA NEGOTIATIONS MAY BE…

TRUMP IMPOSES 100% TARIFF ON BRANDED DRUGS FORMER PRESIDENT TRUMP HAS IMPOSED A 100% TARIFF ON IMPORTED BRANDED DRUGS, RISKING INCREASED COSTS FOR U.S. CONSUMERS, POTENTIAL IMPACT ON INDIAN PHARMACEUTICAL EXPORTS, AND A SIGNIFICANT EFFECT ON GLOBAL PHARMACEUTICAL MARKETS.

TRUMP THREATENS 100% TARIFF ON DRUGS FORMER PRESIDENT TRUMP HAS THREATENED TO IMPOSE A 100% TARIFF ON PRESCRIPTION DRUGS UNLESS PHARMACEUTICAL COMPANIES MANUFACTURE IN THE U.S. || THIS MOVE COULD SIGNIFICANTLY IMPACT THE INDUSTRY AND RAISE CONCERNS ABOUT DRUG PRICES AND…